2020 Q4 Form 10-K Financial Statement

#000143774921005959 Filed on March 12, 2021

View on sec.gov

Income Statement

Concept 2020 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $966.7K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $966.7K
YoY Change
Operating Profit
YoY Change
Interest Expense -$2.056M
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.023M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$442.4K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$177.8K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.8M
YoY Change
Cash & Equivalents $72.00K
Short-Term Investments $138.7M
Other Short-Term Assets $403.2K
YoY Change
Inventory
Prepaid Expenses $403.2K
Receivables
Other Receivables
Total Short-Term Assets $140.2M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$4.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $140.2M
Total Long-Term Assets -$4.00
Total Assets $140.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.914M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $18.00M
YoY Change
Total Long-Term Liabilities $18.00M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.914M
Total Long-Term Liabilities $18.00M
Total Liabilities $22.92M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$21.38M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$21.38M
YoY Change
Total Liabilities & Shareholders Equity $140.2M
YoY Change

Cashflow Statement

Concept 2020 Q4
OPERATING ACTIVITIES
Net Income -$442.4K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$706.0K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$138.7M
YoY Change
Cash From Investing Activities -$138.7M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.5M
YoY Change
NET CHANGE
Cash From Operating Activities -706.0K
Cash From Investing Activities -138.7M
Cash From Financing Activities 140.5M
Net Change In Cash 1.095M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$706.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Assets
Assets
140241606
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001823587
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Public Float
EntityPublicFloat
137620848
CY2020 dei Entity Registrant Name
EntityRegistrantName
Yellowstone Acquisition Co
CY2020 dei Entity Shell Company
EntityShellCompany
true
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4913543
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2081
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12b Title
Security12bTitle
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant
CY2020 dei Trading Symbol
TradingSymbol
ysac
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
153928
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5444155
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
7961119
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
7719779
CY2020Q4 us-gaap Cash
Cash
1122194
CY2020Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
138716226
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1122194
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1122194
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed the Federal Depository Insurance Coverage of <div style="display: inline; font-style: italic; font: inherit;">$250,000.</div> At <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>the Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced losses on these accounts and management believes the Company is <div style="display: inline; font-style: italic; font: inherit;">not</div> exposed to significant risks on such accounts.</div></div></div>
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
7961119
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
126379
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
126379
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
126379
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
12297
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
241748
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
126379
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-93745
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-32634
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
153928
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
403186
us-gaap Interest Paid Net
InterestPaidNet
CY2020Q4 us-gaap Liabilities
Liabilities
4913543
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140241606
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140532255
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-138701849
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-708212
us-gaap Net Income Loss
NetIncomeLoss
-444576
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2178
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-442398
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-458954
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
444576
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3201504
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
404701849
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
403186
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
7719779
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
266000000
us-gaap Professional Fees
ProfessionalFees
146664
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-444576
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000001
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
22822
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
70542
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
14378
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4581931
CY2020Q4 ysac Business Combination Minimum Percentage Of Voting Interest Acquired
BusinessCombinationMinimumPercentageOfVotingInterestAcquired
0.5
ysac Business Combination Period From Ipo For Mandatory Combination
BusinessCombinationPeriodFromIpoForMandatoryCombination
P1Y90D
CY2020Q4 ysac Business Combination Required Fair Market Value Percentage Of Net Assets Held In Trust Account
BusinessCombinationRequiredFairMarketValuePercentageOfNetAssetsHeldInTrustAccount
0.8
CY2020Q4 ysac Business Combination Required Net Tangible Assets
BusinessCombinationRequiredNetTangibleAssets
5000001
ysac Change In Value Of Common Stock Subject To Redmption
ChangeInValueOfCommonStockSubjectToRedmption
10076252
CY2020Q4 ysac Common Stock Voting Rights Per Share
CommonStockVotingRightsPerShare
1
CY2020Q4 ysac Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
4759615
ysac Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRatePercent
0.2843
CY2020Q4 ysac Equity Issued During Period Price Per Unit
EquityIssuedDuringPeriodPricePerUnit
10.20
ysac Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
120251810
ysac Maximum Dissolution Expenses Failure To Complete Business Combination
MaximumDissolutionExpensesFailureToCompleteBusinessCombination
100000
CY2020Q4 ysac Overallotment Reduction Value
OverallotmentReductionValue
CY2020Q4 ysac Percentage Of Shares Mandatorily Redeemed If Fail To Complete Business Combination
PercentageOfSharesMandatorilyRedeemedIfFailToCompleteBusinessCombination
1
CY2020Q4 ysac Reclassification To Temporary Equity Value
ReclassificationToTemporaryEquityValue
130328063
CY2020Q4 ysac Stock Redeemed Maximum Percentage Of Outstanding Shares
StockRedeemedMaximumPercentageOfOutstandingShares
0.15
CY2020Q4 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount
UnderwritingAgreementCashUnderwritingDiscountAggregateAmount
2500000
CY2020Q4 ysac Underwriting Agreement Cash Underwriting Discount Aggregate Amount Including Underwriter Shares
UnderwritingAgreementCashUnderwritingDiscountAggregateAmountIncludingUnderwriterShares
4759615
CY2020Q4 ysac Underwriting Agreement Cash Underwriting Discount Per Unit
UnderwritingAgreementCashUnderwritingDiscountPerUnit
0.20
CY2020Q4 ysac Underwriting Agreement Deferred Fee Per Unit
UnderwritingAgreementDeferredFeePerUnit
0.35

Files In Submission

Name View Source Status
0001437749-21-005959-index-headers.html Edgar Link pending
0001437749-21-005959-index.html Edgar Link pending
0001437749-21-005959.txt Edgar Link pending
0001437749-21-005959-xbrl.zip Edgar Link pending
ex_233506.htm Edgar Link pending
ex_233507.htm Edgar Link pending
ex_233508.htm Edgar Link pending
ex_233509.htm Edgar Link pending
ex_233510.htm Edgar Link pending
ex_233511.htm Edgar Link pending
ex_233538.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kmpg01.jpg Edgar Link pending
kmpg02.jpg Edgar Link pending
kpmg03.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ysac-20201231.xml Edgar Link completed
ysac-20201231.xsd Edgar Link pending
ysac-20201231_cal.xml Edgar Link unprocessable
ysac-20201231_def.xml Edgar Link unprocessable
ysac-20201231_lab.xml Edgar Link unprocessable
ysac-20201231_pre.xml Edgar Link unprocessable
ysac20201231_10k.htm Edgar Link pending